Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/613649


Hong Kong Pharmaceuticals and Healthcare Report Q2 2008


Description: The Hong Kong Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Hong Kongs pharmaceuticals and healthcare industry.

Hong Kong represents a moderately attractive pharmaceutical market for drug-makers. On the positive side, the market is relatively advanced, supported by affluent, urbanised and ageing population, as well as the fact that the government imposes no formal price restrictions. Most recently, the government announced far-reaching reforms of the territory’s healthcare system, which include an increase in budgeted outlay on recurrent medical and health services from the present 15% to 17% in 2011-2012.

Consequently, BMI also upwardly revised its forecast for healthcare spending in Hong Kong., although critics have pointed out that the special administrative region’s spending plan marginalises the elderly and other social issues in favour of more business-oriented expenditure strategy.

Despite the above development, the government will continue to aim to reduce its share of expenditure in the healthcare sector. To this end, authorities are presently considering a proposal to make both medical insurance and medical savings mandatory for workers, which would provide a base for risk-pooling. In addition, the government wants to collaborate with private insurance companies to lower administrative costs, and allow the market to offer competitive services to the population.

In the meantime, Hong Kong retains its position in BMI’s Pharmaceutical Business Environment Ranking table for Q208 out of the 14 markets in the Asia Pacific region. Hong Kong lags behind the large and mature markets of Japan and Australia, and is found between mainland China and Taiwan. In the coming years, the territory is expected to be relegated to lower half of the table, given the rising opportunities provided by nascent markets, such as India in particular. Moreover, the fact that the birth rate in Hong Kong is already below the replacement level will continue represent one of the key factors hampering foreign direct investment (FDI) in the territory’s pharmaceutical sector, alongside a sizeable counterfeit industry and traditional Chinese medicine (TCM) sector that provides competition to over-the-counter (OTC) medicines.

In terms of other developments, the government has recently approached ERM-Hong Kong Limited (ERM) to conduct a Regulatory Impact Assessment (RIA) study. Authorities are aiming to improve the regulation of medical devices, as the importation and sale of medical devices - bar those containing pharmaceutical products or emitting ionising radiation - is presently largely unregulated. The RIA study will assess options and impacts of the legislation of all players in the industry. The Hong Kong’s medical devices market is well-developed, having been stimulated by the economic prosperity enjoyed by the territory in the past.


Contents: Executive Summary
Hong Kong Pharmaceuticals And Healthcare Industry SWOT
Hong-Kong Political SWOT
Hong-Kong Economic SWOT
Hong-Kong Business Environment SWOT
Pharmaceutical Business Environment Ratings
Table: Business Environment Rankings
Limits Of Potential Returns
Risks To Realisation Of Returns
Hong Kong - Market Summary
Regulatory Regime
Other Regulatory Developments
Intellectual Property Issues
Counterfeit Drugs
Pricing and Reimbursement Developments

Industry Trends and Developments
Epidemiology
Healthcare Sector
Table: Secondary/Tertiary Public Sector Health Services In Hong Kong
Healthcare Sector Reforms
Healthcare Financing
Hospital Pharmacy Sector
Public Procurement Of Medicines
Pharmaceutical Industry
Traditional Chinese Medicines
Foreign Industry Developments
Research And Development
Medical Devices
Table Examples Of Medical Devices
Industry Forecast Scene
Overall Market Forecast
Table: Drug Expenditure And Prescription Market Indicators
Key Growth Factors - Industry
Table: Hong Kong’s Health Expenditure Forecast Indicators
Key Growth Factors - Macroeconomic
Table: Economic Activity
Patented Drug Market Forecast
Table: Hong Kong’s Patented Drug Market Indicators (US$mn unless otherwise stated)
Generic Drug Market Forecasts
Table: Hong Kong’s Generics Market Forecast Indicators
OTC Market Forecast
Table: Hong Kong’s OTC Market Forecast Indicators (US$mn unless otherwise stated)
Export/Import Forecasts
Table: Hong Kong Pharmaceuticals Export/Import Trends (US$mn)
Other Healthcare Data And Forecasts
Table: Hong Kong’s Hospital Data Forecasts
Key Risks To our Forecast Scenario
Competitive Landscape
Table: Hong Kong’s Leading Drugmakers And Products, Q406

Company Profiles

Leading Multinational Companies
- GlaxoSmithKline
- Pfizer
- Sanofi-Aventis
- Merck & Co
- Novartis

Local Pharmaceutical Companies
- CK Life Sciences
- South Asia Pharmamedic Ltd
- C&Y Pharmaceutical Investment Holding
- Vida Laboratories

Our Forecast Modelling
How We Generate Our Industry Forecasts
Pharmaceutical Industry
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources



Companies Mentioned - GlaxoSmithKline - Pfizer - Sanofi-Aventis - Merck & Co - Novartis - CK Life Sciences - South Asia Pharmamedic Ltd - C&Y Pharmaceutical Investment Holding - Vida Laboratories


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/613649

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 16/02/2012 08:35:48
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Hong Kong Pharmaceuticals and Healthcare Report Q2 2008
Web Address:
http://www.researchandmarkets.com/reports/613649
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €393.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 16/02/2012 08:35:48

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)